Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase 2/3 1

Status

Recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Prostatic Neoplasms 1427Carcinoma, Renal Cell 587Urinary Bladder Neoplasms 368Kidney Neoplasms 257Carcinoma, Transitional Cell 190Neoplasm Metastasis 163Neoplasms 124Melanoma 83Breast Neoplasms 80Carcinoma, Non-Small-Cell Lung 78Testicular Neoplasms 67Ovarian Neoplasms 62Sarcoma 55Urethral Neoplasms 51Non-Muscle Invasive Bladder Neoplasms 51Wilms Tumor 49Lung Neoplasms 45Colorectal Neoplasms 44Uterine Cervical Neoplasms 39Neuroblastoma 39Penile Neoplasms 37Pancreatic Neoplasms 37Urologic Neoplasms 34Recurrence 32Lymphoma, Non-Hodgkin 32Ureteral Neoplasms 28Osteosarcoma 28Testicular Germ Cell Tumor 26Small Cell Lung Carcinoma 26Head and Neck Neoplasms 26

Interventions

Androgen Antagonists 2zimberelimab 1quemliclustat 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Oligometastatic Prostate Cancer × Genitourinary × Clear all
NCT07490210 2026-03-24

OMPC-RPM

Fudan University

Phase 2 Not yet recruiting
300 enrolled
Genitourinary

Oligometastatic Prostate Cancer

NCT05560659 2025-07-11

POPSTAR II

Peter MacCallum Cancer Centre, Australia

Phase 2 Recruiting
92 enrolled
Genitourinary

Oligometastatic Prostate Cancer

NCT05915442 2025-05-20

SBRT-AMICO

Columbia University

Phase 2 Recruiting
23 enrolled
Genitourinary

Oligometastatic Prostate Cancer

NCT03940235 2023-06-28

RADIOSA

European Institute of Oncology

Phase 2 Unknown
150 enrolled
Genitourinary

Oligometastatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡